Anti-Fas (CD95/Apo-I) autoantibodies and soluble Fas levels concur in T cell depletion in HIV type 1 infection

AIDS Research and Human Retroviruses

Volumn 17, Issue 7, 2001, Pages 603-614

  Silvestris, F ^a   Grinello, D ^a   Del Prete, A ^a   Cafforio, P ^a   Quarto, M ^a   Dammacco, F ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CYTOKERATIN 18; FAS ANTIBODY; FAS ANTIGEN; IMMUNOGLOBULIN G; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL POPULATION; CONTROLLED STUDY; CYTOFLUOROMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; LYMPHOCYTE DEPLETION; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0034928897     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922201300119707     Document Type: Article

References (37)

1. Direct and indirect mechanisms mediating apoptosis during HIV infection: Contribution to in vivo CD4 T cell depletion
2. + T cells from human immunodeficiency virus-infected asymptomatic individuals
3. Fas transduces activation signals in normal human T lymphocytes
4. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals
5. Overexpression of Fas antigen on T cells in advanced HIV-1 infection: Differential ligation constantly induces apoptosis
6. Autocrine T cell suicide mediated by APO-1 (Fas/CD95)
7. Upregulation of Fas ligand secretion in non lymphopenic stages of HIV-1 infection
8. Cross-linking of Fas by antibodies to a peculiar domain of gp120 V3 loop can enhance T cell apoptosis in HIV-1 infected patients
9. Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children
10. Human ICE/CED-3 protease nomenclature
11. Elevated serum levels of soluble Fas/APO-I in human immunodeficiency virus-infected individuals
12. Membrane and soluble forms of Fas (CD95) and Fas ligand in peripheral blood mononuclear cells and in plasma from human immunodeficiency virus-infected persons
13. Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease
14. Characterization of soluble HLA molecules and quantitative HLA differences in serum of healthy individuals
15. Evaluation of soluble tumor necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematosus, progressive systemic sclerosis, and mixed connective tissue disease
16. Soluble Fas (APO-I, CD95) and soluble Fas ligand in rheumatic diseases
17. Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection
18. Tumor necrosis factor β and soluble APO-1/Fas independently predict progression to AIDS in HIV seropositive patients
19. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes
20. An N-terminal domain shared by Fas/APO-I (CD95) soluble variants prevents cell death in vitro
21. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
22. Identification of soluble APO-1 in supernatants of human B and T cell lines and increased serum levels in B and T cell leukemias
23. Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1 infected children
24. 1992 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescent and adults
25. Immunogenicity of an eight aminoacid domain shared by Fas (CD95/Apo-I) and HIV-1 gp120. I. Structural and antigenic analysis
26. Monitoring early cellular responses in apoptosis is aided by the mitochondrial membrane protein-specific monoclonal antibody APO2.7
27. VEINCTR-N, an immunogenic epitope of Fas (CD95/Apo-I), and soluble Fas enhance T cell apoptosis in vitro. II. Functional analy-sis and possible implications in HIV-1 disease
28. Fas-L upregulation by highly malignant myeloma plasma cells: Role in the pathogenesis of anemia and disease progression
29. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis
30. + T cell reactive IgG and IgM in human immunodeficiency virus (HIV-1) infection
31. Plasma membrane alterations and cytoskeletal changes in apoptosis
32. Cloning of a potential soluble receptor for human GM-CSF
33. Increased serum concentration of soluble HLA-DR antigens in HIV infection and following transplantation
34. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas blocks the killing
35. Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death domain receptor
36. A novel protein that interacts with the death domain of Fas/ApoI contains a sequence motif related to the death domain
37. Self-association of the "death domain" of the p55 tumor necrosis factor (TNF) receptor and Fas/ApoI prompts signaling for TNF and Fas/ApoI effects